chemmart amlodipine/atorvastatin 5/40 amlodipine (as besilate) + atorvastatin (as ca propylene glycol solvate) 5mg/40mg film-coa
apotex pty ltd - amlodipine besilate,atorvastatin calcium propylene glycol solvate -
chemmart amlodipine/atorvastatin 5/80 amlodipine (as besilate) + atorvastatin (as ca propylene glycol solvate) 5mg/80mg film-coa
apotex pty ltd - amlodipine besilate,atorvastatin calcium propylene glycol solvate -
terry white chemists amlodipine/atorvastatin 5/40 amlodipine and atorvastatin 5mg/40mg film-coated tablet blister pack
apotex pty ltd - amlodipine besilate,atorvastatin calcium propylene glycol solvate -
blooms the chemist amlodipine/atorvastatin 5/40 amlodipine and atorvastatin 5mg/40mg film-coated tablet blister pack
apotex pty ltd - amlodipine besilate,atorvastatin calcium propylene glycol solvate -
apo-amlodipine
apotex nz ltd - amlodipine besilate 14mg equivalent to to 10 mg amlodipine; - tablet - 10 mg - active: amlodipine besilate 14mg equivalent to to 10 mg amlodipine excipient: lactose monohydrate magnesium stearate maize starch microcrystalline cellulose - apo-amlodipine is indicated for the first line treatment of hypertension and can be used as the sole agent to control blood pressure in the majority of patients. patients not adequately controlled on a single antihypertensive agent may benefit from the addition of amlodipine, which has been used in combination with a thiazide diuretic, beta adrenoceptor blocking agent, or an angiotensin-converting enzyme inhibitor. apo-amlodipine is indicated for the first line treatment of myocardial ischaemia, whether due to fixed obstruction (stable angina) and/or vasospasm/vasoconstriction (prinzmetal's or variant angina) of coronary vasculature. amlodipine may be used where the clinical presentation suggests a possible vasospastic/vasoconstrictive component but where vasospasm/vasoconstriction has not been confirmed. apo-amlodipine may be used alone as monotherapy, or in combination with other antianginal drugs in patients with angina that is refractory to nitrates and/or beta blockers.
apo-amlodipine
apotex nz ltd - amlodipine besilate 3.5mg equivalent to 2.5 mg amlodipine; - tablet - 2.5 mg - active: amlodipine besilate 3.5mg equivalent to 2.5 mg amlodipine excipient: lactose monohydrate magnesium stearate maize starch microcrystalline cellulose - apo-amlodipine is indicated for the first line treatment of hypertension and can be used as the sole agent to control blood pressure in the majority of patients. patients not adequately controlled on a single antihypertensive agent may benefit from the addition of amlodipine, which has been used in combination with a thiazide diuretic, beta adrenoceptor blocking agent, or an angiotensin-converting enzyme inhibitor. apo-amlodipine is indicated for the first line treatment of myocardial ischaemia, whether due to fixed obstruction (stable angina) and/or vasospasm/vasoconstriction (prinzmetal's or variant angina) of coronary vasculature. amlodipine may be used where the clinical presentation suggests a possible vasospastic/vasoconstrictive component but where vasospasm/vasoconstriction has not been confirmed. apo-amlodipine may be used alone as monotherapy, or in combination with other antianginal drugs in patients with angina that is refractory to nitrates and/or beta blockers.
apo-amlodipine
apotex nz ltd - amlodipine besilate 7mg equivalent to to 5 mg amlodipine; - tablet - 5 mg - active: amlodipine besilate 7mg equivalent to to 5 mg amlodipine excipient: lactose monohydrate magnesium stearate maize starch microcrystalline cellulose - apo-amlodipine is indicated for the first line treatment of hypertension and can be used as the sole agent to control blood pressure in the majority of patients. patients not adequately controlled on a single antihypertensive agent may benefit from the addition of amlodipine, which has been used in combination with a thiazide diuretic, beta adrenoceptor blocking agent, or an angiotensin-converting enzyme inhibitor. apo-amlodipine is indicated for the first line treatment of myocardial ischaemia, whether due to fixed obstruction (stable angina) and/or vasospasm/vasoconstriction (prinzmetal's or variant angina) of coronary vasculature. amlodipine may be used where the clinical presentation suggests a possible vasospastic/vasoconstrictive component but where vasospasm/vasoconstriction has not been confirmed. apo-amlodipine may be used alone as monotherapy, or in combination with other antianginal drugs in patients with angina that is refractory to nitrates and/or beta blockers.
olmesartan/amlodipine 20/10 apotex olmesartan medoxomil 20 mg / amlodipine (as besilate) 10 mg tablet blister pack
arrotex pharmaceuticals pty ltd - amlodipine besilate, quantity: 13.87 mg (equivalent: amlodipine, qty 10 mg); olmesartan medoxomil, quantity: 20 mg - tablet, film coated - excipient ingredients: magnesium stearate; silicified microcrystalline cellulose; pregelatinised maize starch; croscarmellose sodium; colloidal anhydrous silica; titanium dioxide; purified talc; iron oxide yellow; iron oxide red; polyvinyl alcohol; macrogol 3350 - it is indicated for the treatment of hypertension. treatment should not be initiated with this fixed-dose combination (see dosage and administration).
apo-atorvastatin atorvastatin (as calcium propylene glycol solvate) 40 mg film-coated tablet blister pack
apotex pty ltd - atorvastatin calcium propylene glycol solvate -
apo-atorvastatin atorvastatin (as calcium propylene glycol solvate) 20 mg film-coated tablet blister pack
apotex pty ltd - atorvastatin calcium propylene glycol solvate -